Pathos AI, Inc., a clinical-stage AI and technology company advancing its own therapeutic pipeline of drugs, today announced ...

Tempus to build a de-identified dataset from hundreds of thousands of patients with neurological conditions; Pathos to ...

Building a new vehicle has traditionally been a slow-motion exercise, with decisions made years before buyers ever see the ...

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant ...

On-device AI chip startup Mobilint was named lead researcher for South Korea's $606M K-On-Device program, tasked with ...

ChatGPT maker OpenAI is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite of products.

About this seriesThis is a series that organizes the recurring failures in workplaces where AI is used to write programs for ...

These questions over whether AI belongs in the classroom is so polarizing that we cannot put this burden solely on the ...

Collaboration combines Vistagen’s neuroscience expertise and datasets with GATC Health’s predictive modeling capabilities to provide additional insights for protocol development and resource allocatio ...

As artificial intelligence (AI) permeates more fields and applications, organizations may find that it proves difficult to wield without the right knowledge and skill set. That’s why software ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today ...